Category Archives: Tuberculosis (TB)

Here’s the short note on UNHLM on TB and US pressurising to dilute TRIPS flexibilities

The United Nations is going to hold a High Level Meeting on TB in New York in September. The member countries of UN will sign on a declaration will set the direction in which work on TB, globally, will move. … Continue reading

Posted in TRIPS, TRIPS flexibilities, Tuberculosis (TB), US Pressure | Leave a comment

Draft TB declaration: US, EU push against funding, delinkage pledges

Source: POLITICO PRO| June 12, 2018 The EU and U.S. are resisting concrete commitments on new funding for tuberculosis ahead of a high-level U.N. meeting about fighting the world’s top infectious killer. The two regions are also pushing to eliminate language … Continue reading

Posted in Delinkage, Tuberculosis (TB) | Leave a comment

India’s ailing battle against TB: One in five multidrug-resistant patients do not complete treatment

By Swagata Yadava, FirstPost | April 10, 2018 New Delhi: Nearly one in five multidrug-resistant (MDR) tuberculosis (TB) patients put on treatment in the public sector were lost to follow-up (LFU). This means that they either did not start treatment or … Continue reading

Posted in Tuberculosis (TB), Uncategorized | Leave a comment

जानलेवा टीबी वापस लौट रहा है

बीसवीं सदी की शुरुआत में टीबी जानलेवा थी. फिर उसका इलाज ढूंढ लिया गया. लगने लगा टीबी पर काबू हो गया. लेकिन आज फिर जानलेवा टीबी वापस लौट रहा है. अपने ख़तरनाकर रूप में जिसे MDRTB कहा जाता है.   … Continue reading

Posted in Tuberculosis (TB), Uncategorized | Leave a comment

Report of the First National Anti- Tuberculosis drug resistance survey: India 2014-2016

By Ministry of Health & Family Welfare India is one of the highest burden countries for TB and MDR-TB. However, the epidemiology of DR-TB in India has never been studied nationally. This is essential to measure the DR-TB burden and to guide … Continue reading

Posted in Tuberculosis (TB), Uncategorized | Leave a comment

Time to explore the licence to make new TB drugs more accessible

By Leena Menghaney, The Hindu BusinessLine | March 16, 2018 The World Health Organization (WHO) estimates that tuberculosis (TB) prevalence is decreasing at a rate of about 2 per cent per year worldwide and that timely diagnosis and treatment have … Continue reading

Posted in Compulsory Licensing, TRIPS flexibilities, Tuberculosis (TB), Uncategorized | Leave a comment

Indian civil society pushes for ‘Government Use’ compulsory license on MDR-TB Drugs

Source: Lawyers Collective | 12 March 2018 Survivors of drug resistant tuberculosis, health organisations and the TB community in India and across the globe have appealed to the Prime Minister of India to issue a government use compulsory license for … Continue reading

Posted in Compulsory Licensing, TRIPS flexibilities, Tuberculosis (TB), Uncategorized | Leave a comment